Mario Gabelli Reveales Latest Moves In Its Equity Portfolio
Mario Gabelli's fund GAMCO Investors and its affiliates, have revealed in several filings with the SEC, some of the latest moves related to the holdings in its equity portfolio.
Hi Tech Pharmacal Co Inc (HITK)
This company is not actively trading or the ticker does belong to another company in our database now.
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 0 | $0 | 0% | |
| 2. | Springbok Capital Gavin Saitowitz And Cisco J. Del Valle | 0 | $0 | 0% | |
| 3. | Stevens Capital Management Matthew Tewksbury | 0 | $0 | 0% | |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% | |
| 5. | GAMCO Investors Mario Gabelli | 0 | $0 | 0% |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $43.06 | 6,873 | $295,951.38 | 0 | 2013-12-13 | Filing | |
| $43.13 | 11,250 | $485,212.50 | 521,510 | 2013-10-10 | Filing | |
| $43.09 | 23,000 | $991,070.00 | 1,290,703 | 2013-10-08 | Filing | |
| $43.10 | 1,500 | $64,650.00 | 0 | 2013-10-04 | Filing | |
| $43.14 | 10,100 | $435,714.00 | 0 | 2013-10-02 | Filing |
Institutional Investors' Holdings
News See All
Cadence Pharmaceuticals, Inc. (CADX), Griffin Land & Nurseries, Inc. (GRIF) and Three Other Moves From Mario Gabelli and GAMCO Investors
As usual, Mario Gabelli has been very active this week. His fund, GAMCO Investors, has reported two new positions and has increased its investment in three other companies.
How to Play Merger Arbitrage Cliff Asness Style
In a filing with the SEC, AQR reported owning 805,203 shares of TMS International, which have a total value of some $14.07 million, at the current stock price of the company. In a second filing, the...
Do Hedge Funds and Insiders Love Akorn, Inc. (AKRX)?
To many of your peers, hedge funds are viewed as useless, old investment tools of an era lost to time.
Akorn, Inc. (AKRX), Hi-Tech Pharmacal Co. (HITK): The New Leader in Ophthalmology
This space has a bright future outlook, and according to Markets and Markets, it is projected to reach a market size of $36 billion by 2014, increasing at a CAGR of 5.4% during 2009-2014.
Hedge Funds Are Betting On Momenta Pharmaceuticals, Inc. (MNTA)
Now, according to many market players, hedge funds are assumed to be bloated, outdated investment tools of a period lost to current times.
Hi-Tech Pharmacal Co. (HITK): Hedge Funds Aren't Crazy About It, Insider Sentiment Unchanged
To the average investor, there are tons of gauges investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity.
This Metric Says You Are Smart to Buy Sagent Pharmaceuticals Inc (SGNT)
If you were to ask many of your fellow readers, hedge funds are seen as useless, old investment tools of a forgotten age.
Why Akorn, Inc. (AKRX) and Hi-Tech Pharmacal Co. (HITK)'s Shares Soared
What: Shares of branded and generic drug developer Akorn, Inc. (NASDAQ:AKRX) and branded, generic and over-the-counter drugmaker Hi-Tech Pharmacal Co. (NASDAQ:HITK) soared as much as 15% and 26%, ...
Harley-Davidson, Inc. (HOG), Hi-Tech Pharmacal Co. (HITK): Four Rules to Follow This Earnings Season
Alcoa unofficially kicked off earnings season on Monday and traded flat for most of Tuesday after a mixed quarter.